In-vivo Imaging Market Analysis

Modality (Nuclear Imaging Systems, Optical Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems)

The micro-MRI segment is estimated to hold 21% share of the global in-vivo imaging market in the coming years owing to the growing usage in small animal imaging. In vivo, 3D imaging of microstructure in small animals such as mice and rats is made easier with the use of micro-MRI since small animal models play a crucial role in cardiovascular investigation and help researchers in studying In-vivo molecular pathways in cardiovascular pathology.

Techniques (Biomarkers Based, Luminescent Proteins Based, Radioisotopes Based)

The radioisotopes based segment is set to garner a notable share shortly. Radioisotope-based based In-vivo imaging is widely used in preclinical research to study diseases in living organisms. For instance, positron emission tomography (PET) is an imaging technique that uses radioisotopes to inject a small amount of radioactive glucose into the veins of animals to study metabolic processes and more.

Our in-depth analysis of the global market includes the following segments:

Modality	Optical Imaging Systems Nuclear Imaging Systems Micro-MRI Micro-Ultrasound Micro-CT Photoacoustic Imaging Systems Magnetic Particle Imaging Systems
Techniques	Radioisotopes Based Biomarkers Based Luminescent Proteins Based
End-User	Hospitals and Clinics Imaging Centers Research Organizations
Reagents	Optical Imaging Reagents Nuclear Imaging Reagents MRI Contrast Agents Ultrasound Contrast Agents CT Contrast Agents

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in-vivo imaging is estimated at USD 1.21 billion.

The in-vivo imaging market size was over USD 1.15 billion in 2024 and is poised to cross USD 2.64 billion by the end of 2037, growing at more than 6.6% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of cancer across the globe and the rising trend of precision medicine will drive the market growth.

Asia Pacific industry is set to account for largest revenue share 46% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

In-vivo Imaging Market Analysis